XML 34 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Common Stock and Stockholders' Equity (Tables)
9 Months Ended
Dec. 31, 2015
Equity [Abstract]  
Schedule of Stock Option and RSU Award Activities

The following table summarizes the Company’s stock option and RSU award activities for the nine months ended December 31, 2015 (in thousands, except per share information):

 

     Options Outstanding      RSUs Outstanding  
                  Weighted-
Average
Remaining
Contractual
Term
(in years)
                  Weighted-
Average
Grant
Date

Fair
Value
     Weighted-
Average
Remaining
Contractual
Term
(in years)
        
     Number
of Shares
    Weighted-
Average
Exercise
Price
        Aggregate
Intrinsic
Value
     Number
of Shares
          Aggregate
Intrinsic
Value
 

Outstanding - April 1, 2015

     9,422      $ 10.08         7.9       $ 231,964         723      $ 23.87         3.5       $ 25,098   

Stock options granted

     621        32.92                    

RSUs granted

                1,008        33.48         

Stock options exercised

     (1,921     5.49            56,534              

RSUs vested

                (123     25.07         

Stock options canceled/forfeited

     (545     15.77                    

RSUs canceled/forfeited

                (107     26.97         
  

 

 

            

 

 

         

Outstanding - December 31, 2015

     7,577      $ 12.71         6.7       $ 179,964         1,501      $ 30.01         3.3       $ 54,682   
  

 

 

            

 

 

         
Schedule of Stock-based Compensation Expense Attributed to Cost of Revenue, Research and Development, Sales and Marketing and General and Administrative Expenses

Stock-based compensation expense attributed to cost of revenue, research and development, sales and marketing, and general and administrative expenses were as follows (in thousands):

 

     Three Months Ended December 31,      Nine Months Ended December 31,  
     2015      2014      2015      2014  

Cost of revenue

   $ 333       $ 166       $ 893       $ 359   

Research and development

     1,684         721         4,223         1,178   

Sales and marketing

     2,588         1,474         6,634         3,378   

General and administrative

     1,751         1,065         4,853         2,677   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation expense

   $ 6,356       $ 3,426       $ 16,603       $ 7,592